Literature DB >> 9796737

Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro.

S Jiang1, S Tugulea, G Pennesi, Z Liu, A Mulder, S Lederman, P Harris, R Cortesini, N Suciu-Foca.   

Abstract

The induction of regulatory T cells may offer an effective means for specific immunosuppression of autoimmune disease and allograft rejection. The existence of suppressor T cells has been previously documented, yet their mechanism of action remains poorly characterized. Our studies demonstrate that T suppressor (Ts) cell lines can be generated by in vitro immunization of human PBMCs, with synthetic peptides or soluble proteins coupled to beads. Such Ts cells express the CD8+CD28- phenotype and show the following characteristics: (a) antigen specificity and restriction by self MHC Class I molecules; (b) limited TCR V beta gene usage; (c) ability to inhibit antigen-specific, MHC Class II restricted, Th proliferative responses; and (d) capacity to downregulate and/or inhibit the upregulation by Th of CD40, CD80, and CD86 molecules on APCs. The inhibitory activity of Ts on Th proliferation requires the tripartite interaction between Th, Ts, and APCs and results from inefficient costimulation of Th.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796737     DOI: 10.1016/s0198-8859(98)00073-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  18 in total

Review 1.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

2.  Regulatory functions of CD8+CD28- T cells in an autoimmune disease model.

Authors:  Nader Najafian; Tanuja Chitnis; Alan D Salama; Bing Zhu; Christina Benou; Xueli Yuan; Michael R Clarkson; Mohamed H Sayegh; Samia J Khoury
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 3.  An integrated view of suppressor T cell subsets in immunoregulation.

Authors:  Hong Jiang; Leonard Chess
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 4.  CD8(+) Tregs in autoimmunity: learning "self"-control from experience.

Authors:  Sue Tsai; Xavier Clemente-Casares; Pere Santamaria
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

Review 5.  Working out mechanisms of controlled/physiologic inflammation in the GI tract.

Authors:  Keren Rabinowitz; Lloyd Mayer
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 6.  Inhibitory CD8+ T cells in autoimmune disease.

Authors:  Masakatsu Suzuki; Christine Konya; Jörg J Goronzy; Cornelia M Weyand
Journal:  Hum Immunol       Date:  2008-09-21       Impact factor: 2.850

7.  Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.

Authors:  Juergen L Foell; Belkis I Diez-Mendiondo; Oliver H Diez; Ursula Holzer; Peter Ruck; Abhijit S Bapat; Michael K Hoffmann; Robert S Mittler; Guenther E Dannecker
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

8.  Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking.

Authors:  Janina Mertens; Mario Fabri; Alessandra Zingarelli; Torsten Kubacki; Sonja Meemboor; Laura Groneck; Jens Seeger; Martina Bessler; Helena Hafke; Margarete Odenthal; Joan G Bieler; Christoph Kalka; Jonathan P Schneck; Hamid Kashkar; Wiltrud M Kalka-Moll
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

Review 9.  The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS).

Authors:  Mohammed A Al Jumah; Mohamed H Abumaree
Journal:  Int J Mol Sci       Date:  2012-07-24       Impact factor: 6.208

10.  Thymic versus induced regulatory T cells - who regulates the regulators?

Authors:  Giovanni Antonio Maria Povoleri; Cristiano Scottà; Estefania Andrea Nova-Lamperti; Susan John; Giovanna Lombardi; Behdad Afzali
Journal:  Front Immunol       Date:  2013-06-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.